We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IMCD market cap is 7.33B. The company's latest EPS is EUR 5.1286 and P/E is 25.15.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.71B | 2.79B | 3.46B | 4.63B | 4.47B |
| Operating Income | 176.17M | 190.34M | 305.5M | 461.73M | 428.5M |
| Net Income | 108.01M | 120.13M | 207.28M | 313.08M | 292.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 2.19B | 2.7B | 3.27B | 3.64B | 4.15B |
| Total Liabilities | 1.32B | 1.44B | 1.81B | 1.97B | 2.43B |
| Total Equity | 866.53M | 1.25B | 1.46B | 1.67B | 1.73B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 174.15M | 232.01M | 196.26M | 298.84M | 420.01M |
| Investing | -107.43M | -390.02M | -196.13M | -255.36M | -394.59M |
| Financing | -40.68M | 246.44M | 4.73M | -20k | 216.97M |
| Market Cap | 7.33B |
| Price to Earnings Ratio | 25.15 |
| Price to Sales Ratio | 1.64 |
| Price to Cash Ratio | 18.64 |
| Price to Book Ratio | 4.26 |
| Dividend Yield | - |
| Shares Outstanding | 56.99M |
| Average Volume (1 week) | 161.28k |
| Average Volume (1 Month) | 125.79k |
| 52 Week Change | -19.06% |
| 52 Week High | 169.05 |
| 52 Week Low | 126.65 |
| Spread (Intraday) | 0.05 (0.04%) |
| Company Name | IMCD NV |
| Address |
wilhelminaplein 32 rotterdam, south holland 3072 DE |
| Website | https://www.imcdgroup.com |
| Industry | chemicals & chem preps, nec (2899) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
